Role Summary
You will be responsible for scientific oversight, data integrity and quality of clinical trial(s) in support of the development strategy for programs within the Late-Stage Oncology portfolio.
Responsibilities
- Clinical development expert for assigned studies maintaining current scientific and clinical knowledge in the specific therapeutic and disease area(s) of assignment.
- Effectively partner with other clinical and medical colleagues, clinical operations and other functional lines for the successful implementation and execution of the clinical trial(s) within the assigned program.
- Responsible for scientific oversight, data integrity and quality of the clinical trial(s).
- Represent the study team in governance meetings and submissions, partners with/supports the Development lead/Medical Director regarding study and disease area strategy.
- Author protocols, study level informed consent documents, and contributes to authoring of IBs, site training materials, clinical study reports, regulatory responses, and other clinical and regulatory documents; supports preparations for Health Authority meetings, participates as appropriate.
- Set the clinical data review strategy and leads the team in the collection of quality data and review of emerging clinical data and trends; reviews and queries data; presents and discusses relevant data to appropriate teams, governance bodies, and other internal and external stakeholders.
- In close partnership with medically qualified colleague/s, analyze the emerging safety profile of the drug, keeping the clinical and safety colleagues informed of changes in the safety profile as they occur in the assigned trial(s).
- Follow relevant SOPs and regulations, has an excellent understanding of and complies with applicable trainings, seeks opportunities to further improve quality and efficiency of clinical procedures; leads or actively participates in portfolio- and enterprise level workgroups aimed at optimizing PFE clinical development procedures; may be a subject matter expert or business process owner for a relevant SOP or procedure.
Qualifications
- Required: PhD/Pharm D in a relevant science discipline with minimum 5 years of Clinical Research experience in industry/CRO, or MS with minimum 7 years, or BA/BS with minimum 10 years in a similar role in industry/CRO.
- Required: Clinical Research experience in the phase 3/pivotal space in Oncology, ideally on the sponsor side with a track record of successful regulatory submission, inspection, and regulatory approval.
- Required: Excellent knowledge of clinical procedures, ICH guidelines, GCP and familiarity with FDA, EMA, and global regulations.
- Required: Extensive understanding of related disciplines (Clinical Operations, Safety, Biostatistics, Regulatory, Study Management, Pre-clinical, Pharmacology, Quality Assurance).
- Required: Experience working on large data sets; Proficiency with Microsoft Office and relevant scientific software.
- Required: Effective communication, presentation, and organizational skills; experience leveraging diverse communication tools to convey results; ability to solve problems collaboratively and handle conflict constructively; track record of scientific productivity (publications, posters, abstracts, presentations); ability to work proactively and independently; ability to build partnerships across the company to achieve program needs.
- Preferred: Experience in Hematology Oncology.
- Travel/Location: Work Location Assignment – hybrid role requiring you to live within commuting distance and work on-site an average of 2.5 days per week.
Skills
- Strong leadership and collaboration capabilities with cross-functional teams.
- Strategic thinking combined with practical operational execution.
- High tolerance for ambiguity and ability to drive decisions in a complex regulatory environment.
- Scientific productivity and ability to communicate complex data to diverse audiences.
- Global perspective and ability to work in a diverse, multi-cultural team.